Hudson Technologies (NASDAQ:HDSN) Surprises With Q2 CY2026 Sales

Hudson Technologies (NASDAQ:HDSN) reported Q2 CY2026 revenue of $78.35 million, up 7.5% year on year and 5.6% above Wall Street estimates, according to the company. GAAP EPS was $0.12, below consensus and down from $0.23 a year earlier. Management cited selling-season growth despite HFC price weakness and inflation. Shares fell 1.5% to $6.12 after the release.

Original reporting
Published Aug 5, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Hudson Technologies (NASDAQ:HDSN) Surprises With Q2 CY2026 Sales — source image
Decision brief

The 30-second read

$HDSNNeutralMed
01

Why it matters

The key trade setup is the divergence between a revenue beat and an EPS miss, alongside guidance expectations for flat revenue over the next 12 months and a decline in operating margin.

02

Market read

Q2 revenue beat and volume growth exceeded expectations, but EPS and operating margin declined, creating a mixed catalyst for near-term positioning.

03

What to watch

Operating margin fell to 9.4% and management cites HFC price trough and inflation; traders should weigh whether these headwinds worsen into subsequent quarters despite the partnership headline.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session reaction to Q2 results reported today

Background

Hudson Technologies provides refrigerant sales, reclamation, and recycling, and management says the selling season is underway.

Company-level read

Ticker impact

$HDSNNeutralMedium confidence
Context

Hudson Technologies reported Q2 CY2026 revenue of $78.35M, up 7.5% YoY and 5.6% above estimates, while EPS was $0.12 and missed consensus.

Expected impact

Likely choppy trading, with upside bias if investors focus on the revenue/volume beat and partnership/capacity expansion, but downside risk if EPS weakness persists.

Evidence & confidence

The article provides concrete Q2 revenue and EPS figures plus commentary on HFC price trough and inflationary headwinds, which can explain the divergence and drive follow-through volatility.

Market effects

Signals ongoing margin pressure in refrigerant services amid HFC price trough and inflation, even when volumes hold up.

No specific regional impact described beyond US-listed industrials sentiment.

No direct global macro linkage beyond commodity-linked HFC pricing referenced in management commentary.

Counterpoint

The EPS miss may be temporary if volume growth and capacity investments translate into operating leverage later, making the revenue beat the more durable signal.

Key entities

  • Hudson Technologies

    NASDAQ-listed refrigerant services firm reporting Q2 CY2026 results and discussing HFC price and inflation headwinds plus a preliminary advanced separation technology partnership.

Related articles

$HDSNMed

Hudson Technologies Q2 Earnings Call Highlights

Hudson Technologies (NASDAQ:HDSN) reported Q2 revenue of $78.3 million, up 8% year over year, with sales volume up 12% but average refrigerant selling price down 6%. Gross margin fell to 26% from 31% a year earlier. The company revised its FY2026 gross-margin target to the low-to-mid-20% range and said the Defense Logistics Agency re-awarded a five-year $210 million contract.

$HDSNMed

HUDSON TECHNOLOGIES INC /NY (HDSN): Results of Operations and Financial Condition

HUDSON TECHNOLOGIES INC /NY (HDSN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622080d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 HUDSON TECHNOLOGIES REPORTS SECOND quarter 2026 reSults Second quarter revenue grew 8% driven by strong volume Posts trailing twelve month double-digit volume growth Operations fully restored at tornado impacted facility

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.